On November 14, 2019 Medicenna Therapeutics Corp. ("Medicenna" or "the Company") (TSX: MDNA,OTCQB: MDNAF), a clinical stage immuno-oncology company, reported that key opinion leaders, Dr. Sampson and Dr. Butowski, will present updated results from the Phase 2b clinical trial of MDNA55 for the treatment of recurrent glioblastoma ("rGBM") at the 24th Annual Meeting of the Society of Neuro-Oncology ("SNO") and 3rd Joint Conference of SNO and Society for CNS Interstitial Delivery of Therapeutics ("SNO-SCIDOT") to be held from November 20 to 24 at the JW Marriott Desert Ridge Resort in Phoenix, Arizona (Press release, Medicenna Therapeutics, NOV 14, 2019, View Source [SID1234551335]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The oral presentations will provide an update on efficacy, safety and data from the MDNA55 Phase 2b clinical trial in patients with rGBM, the most common and deadly form of brain cancer.
Details of the presentations are as follows:
Presenter: Dr. Nicholas Butowski, MD – Professor of Neurological Surgery and Director of Translational Research in Neuro-Oncology at The Helen Diller Family Comprehensive Cancer Center, University of California San Francisco
Title: Convection-Enhanced Delivery (CED) of MDNA55 in Adults with Recurrent Glioblastoma
Date/Time: Wednesday, November 20, 2019 at 3:10 PM MT
Room: Grand Saguaro East
Presenter: Dr. John Sampson, MD, PhD, MHSc, MBA – Robert and Gloria Wilkins Distinguished Professor and Chair of Neurosurgery, Department of Neurosurgery, Duke University School of Medicine
Title: Combating Recurrent Glioblastoma with MDNA55, an Interleukin-4 Receptor Targeted Immunotherapy, Through MRI-Guided Convective Delivery
Date/Time: Sunday, November 24, 2019 at 9:45 AM MT
Room: Grand Canyon 1 – 6